- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 451/04 - Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.02,4] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamineCyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.02,4] nonane ring systems, e.g. tropaneCyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.02,4] nonane ring system
Patent holdings for IPC class C07D 451/04
Total number of patents in this class: 271
10-year publication summary
12
|
22
|
19
|
25
|
28
|
18
|
20
|
23
|
7
|
2
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Theravance Biopharma R&D IP, LLC | 458 |
14 |
Remix Therapeutics Inc. | 79 |
10 |
Skyhawk Therapeutics, Inc. | 110 |
9 |
Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 823 |
8 |
Novartis AG | 10847 |
7 |
Bristol-myers Squibb Company | 4878 |
7 |
Purdue Pharma L.P. | 499 |
7 |
Janssen Pharmaceutica N.V. | 3395 |
6 |
Curza Global, LLC | 29 |
6 |
Shionogi & Co., Ltd. | 858 |
6 |
University of Utah Research Foundation | 1807 |
6 |
Merck Patent GmbH | 5830 |
5 |
Rigel Pharmaceuticals, Inc. | 539 |
5 |
ACADIA Pharmaceuticals Inc. | 205 |
4 |
Astellas Pharma Inc. | 1085 |
4 |
BioMarin Pharmaceutical Inc. | 376 |
4 |
Enanta Pharmaceuticals, Inc. | 428 |
4 |
Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | 302 |
4 |
The University of Edinburgh | 27 |
4 |
Shanghai Hansoh Biomedical Co., Ltd. | 262 |
4 |
Other owners | 147 |